Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
New research shows FAM72 family overexpression predicts poorer liver cancer outcomes and introduces a two-gene FAM72 risk ...
Genomics based research and diagnostic company Strand Life Sciences is planning to give a major push to consumer-centric ...
Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...
North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased ...
Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of ...